Letters to the Editor

Molecular characterization and clinical impact of t(11;15)(q23;q14–15) MLL-CASC5 rearrangement

Department of Medicine, Graduate School Kyung Hee University, Seoul, Korea
Department of Laboratory Medicine, School of Medicine, Kyung Hee University, Seoul, Korea
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Laboratory Medicine, Inje University College of Medicine, Busan, Korea
Green Cross Genome, Yongin, Korea
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung e.V., Vienna, Austria
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung e.V., Vienna, Austria
CCRI, Children’s Cancer Research Institute, St. Anna Kinderkrebsforschung e.V., Vienna, Austria;St. Anna Children’s Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
CLIP (Childhood Leukaemia Investigation Prague) – Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czech Republic
Department of Paediatrics, Faculty Hospital of Palacky University, Olomouc, Czech Republic
Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemia, Goethe-University of Frankfurt, Germany
Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemia, Goethe-University of Frankfurt, Germany
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Vol. 99 No. 1 (2014): January, 2014 https://doi.org/10.3324/haematol.2013.095638